(z)-endoxifen for neoadjuvant treatment of er+ / her2- breast cancer in premenopausal women

TW202639115APending Publication Date: 2026-10-01ATOSSA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114148250
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-12
Filing Date
2025-12-09
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078740_001
    Figure TWG2TA001078740_001
  • Figure TWG2TA001078740_002
    Figure TWG2TA001078740_002
  • Figure TWG2TA001078740_003
    Figure TWG2TA001078740_003
Patent Text Reader

Abstract

Described herein are (Z)-endoxifen compositions and methods using (Z)-endoxifen compositions for treating various cancers, such as hormone-dependent cancers. The (Z)-endoxifen compositions may be used to treat cancers such as breast cancer, medulloblastoma or glioblastoma. A method of treating various cancers may include administering (Z)-endoxifen to a subject having pediatric medulloblastoma or adult-glioblastoma multiforme.
Need to check novelty before this filing date? Find Prior Art